Atomic AI: Unlocking RNA  thumbnail
Atomic AI: Unlocking RNA
www.notboring.co
Atomic AI is a perfect example of the kind of company we want to invest in at Not Boring Capital. It’s built on cutting edge science at the intersection of Bits and Atoms, has a path to becoming a $10B+ company, and as importantly, will bend the world’s trajectory upwards if it succeeds. Specificall
1 Users
0 Comments
50 Highlights
50 Notes

Top Highlights

  • Atomic AI is a perfect example of the kind of company we want to invest in at Not Boring Capital. It’s built on cutting edge science at the intersection of Bits and Atoms, has a path to becoming a $10B+ company, and as importantly, will bend the world’s trajectory upwards if it succeeds.
  • Specifically, by unlocking the structure of RNA, Atomic AI could unlock the potential of RNA-targeting and RNA-based medicines, help cure previously incurable diseases, and save millions of lives.
  • This binary battle between Bits and Atoms is not how we view the world at Not Boring.
  • Atomic AI is building the foundation for AI-driven RNA drug discovery. It uses deep learning to predict the structure of RNA molecules in order to identify druggable targets.
  • If Atomic AI is successful, it will unlock the potential of RNA-targeting and RNA-based medicine. That might mean cures for cancer, more efficient, effective, and safer vaccines, and the opportunity to save and improve millions of lives. Many of the diseases Atomic AI is going after are currently undruggable.

Tags

AI

Ready to highlight and find good content?

Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.